Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
07 Octobre 2024 - 11:07PM
Edgar (US Regulatory)
Exhibit 99.1
The identity and the Item 3 classification of the relevant subsidiary is: Bleichroeder LP, which is an Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
Cue Biopharma (NASDAQ:CUE)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Cue Biopharma (NASDAQ:CUE)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025